Home > Products > Novel inhibitors
Cat. No. Product name CAS No.
DCC4704 Sgi-10067

PKM2 activator, potently inhibiting proliferation of cancer cells in media lacking serine

DCC4705 Sgi-9380

PKM2 activator, potently inhibiting proliferation of cancer cells in media lacking serine

DCC4706 Sgk1 Inhibitor 17a

Novel highly selective SGK1 inhibitor with a highly optimized profile suitable for oral dosing as a potentially disease-modifying agent for osteoarthritis

DCC4707 Sglt1/2-in-8

Novel Potent SGLT1/2 Dual Inhibitor

DCC4708 Sgx393

Novel inhibitor of the CML mutant Bcr-AblT315I, preempting in vitro resistance when combined with nilotinib or dasatinib.

1030610-86-6
DCC4709 Sh-053-r-ch3-2’f

Selective agonist of GABA A receptors α5 subunit

872874-14-1
DCC4710 Sh-053-s-ch3-2'f

Potent and selective agonist of GABAA receptors α5 subunit

872874-00-5
DCC4711 Sh-11037

Novel potent sEH inhibitor, effectively blocking key angiogenic properties of human retinal endothelial cells (HRECs), inhibiting choroidal sprouting and significantly suppressing CNV lesion volume

DCC4712 Sh-11052

Novel inhibitor of endothelial cell growth

DCC4713 Sh-2251

Novel selective inhibitor of the generation of IL-5-producing Th2 cells and induction of active histone modifications at the IL5 gene locus during Th2 cell differentiation

DCC4714 Sha 14-1

Stable and ROS-free antagonist against anti-apoptotic Bcl-2 proteins, bypassing drug resistances and synergizing cancer therapies in human leukemia cell

1033753-87-5
DCC4715 She-196

First in Class Hypoglycemic Agent with Extra-Strong Action, increasing insulin sensitivity, improving glucose tolerance, reducing fasted insulin level and insulin sensitivity, decreasing total body and interscapular fat mass and also increasing the activi

DCC4716 Sherpa Bmi-135

Novel Selective Human ER Partial Agonist (ShERPA)

DCC4717 Sheta2

Selective inhibitor of cancer cell growth, exerting chemoprevention activity without evidence of toxicity

361483-66-1
DCC4718 Sh-i-14

Novel Inhibitor of Phospho-STAT3 Through Induction of Protein Tyrosine Phosphatase PTPN6

DCC4719 Shield-2

Novel potent stabilizing ligand for FKBP-derived destabilizing domains

1013621-70-9
DCC4720 Ship-2a

Cystathione gamma lyase (CSE) inhibitor, inhibiting H2S production and L-cysteine-induced relaxation of rat aortic rings ex vivo

1250186-20-9
DCC4721 Showdomycin

Antineoplastic antibiotic

16755-07-0
DCC4722 Shp2 Inhibitor C21

Inhibitor of shp2 protein tyrosine phosphatase (PTP)

293327-21-6
DCC4723 Shr0687

Highly Potent and Peripheral Nervous System-Restricted KOR Agonist

DCC4724 Sibopirdine

Novel cognitive enhancer; Nootropic agent

122955-18-4
DCC4725 Sid-24784551

Novel direct HIV-1 Nef antagonist with antiretroviral activity

332420-75-4
Page 1436 / Total 1558 FirstPrevNextLastGoto